BPC-157 vs TB-500
Updated · Educational, not medical advice
The short answer
BPC-157 is a 15-amino-acid peptide based on a stomach-protein fragment; TB-500 is a synthetic fragment of thymosin beta-4. Both are asked about for injury recovery, both rest mainly on animal research with no controlled human trials showing benefit, neither is FDA-approved, both were recommended for compounding by an FDA advisory committee in July 2026 (pending FDA action), and both are prohibited in sport.
Side by side
Questions
What is the difference between BPC-157 and TB-500?
BPC-157 is a 15-amino-acid peptide based on a stomach-protein fragment; TB-500 is a synthetic fragment of thymosin beta-4. Both are asked about for injury recovery, both rest mainly on animal research with no controlled human trials showing benefit, neither is FDA-approved, both were recommended for compounding by an FDA advisory committee in July 2026 (pending FDA action), and both are prohibited in sport.
Can you take BPC-157 and TB-500 together?
Some clinicians prescribe them together. The combination has not been studied in controlled human trials; your clinician decides whether either, both or neither is appropriate.
Do I need a prescription for BPC-157 or TB-500?
Yes. Both should be prescribed by a licensed clinician and prepared by a licensed pharmacy. Avoid products sold as "research use only".
Sources
- PubMed: published research on BPC-157
- ClinicalTrials.gov: registered studies of BPC-157
- AJMC: FDA panel backs 6 peptides for compounding (July 31, 2026)
- Health Affairs Forefront: the advisory committee's peptide vote
- World Anti-Doping Agency: Prohibited List
- PubMed: published research on thymosin beta-4
- ClinicalTrials.gov: registered studies of thymosin beta 4